Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription 15.04.2019 1 BMJ 5 Clin Infect Dis 5 Infect Immun 7 J Infect Dis 1 JAMA 1 Lancet 4 Lancet Infect Dis 1 MMWR Morb Mortal Wkly Rep 1 Nat Med 1 Pediatr Infect Dis J 1 Pediatrics 2 PLoS One 1 Science 20 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMJ

1. GOPAL DP, Barber J, Toeg D
   Pertussis (whooping cough).
   BMJ. 2019;364:l401.
   PubMed     Text format    
   
   

   
   Clin Infect Dis

2. LINDHOLM DA, Fisher RD, Montgomery JR, Davidson W, et al
   Preemptive Tecovirimat Use in an Active Duty Member Presenting with Acute Myeloid Leukemia after Smallpox Vaccination.
   Clin Infect Dis. 2019 Apr 9. pii: 5432316. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
3. KELLNER JD
   Who Benefits, and How Much? Indirect Effects of Childhood Pneumococcal Vaccination in Adults at Increased Risk of Pneumococcal Disease.
   Clin Infect Dis. 2019;68:1374-1375.
   PubMed     Text format    
   
   
4. STEENS A, Winje BA, White RA, Odsbu I, et al
   Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study.
   Clin Infect Dis. 2019;68:1367-1373.
   PubMed     Text format     Abstract available
   
   
5. KOBAYASHI M, Bigogo G, Kim L, Mogeni OD, et al
   Impact of 10-valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns among Children aged <5 Years and Adults with HIV Infection, Kenya 2009-2013.
   Clin Infect Dis. 2019 Apr 9. pii: 5432315. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
6. MEMOLI MJ, Han A, Walters KA, Czajkowski L, et al
   Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.
   Clin Infect Dis. 2019 Apr 6. pii: 5429562. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Infect Immun

7. ACQUAH FK, Adjah J, Williamson KC, Amoah LE, et al
   Transmission-blocking vaccines: old friends and new prospects.
   Infect Immun. 2019 Apr 8. pii: IAI.00775-18. doi: 10.1128/IAI.00775.
   PubMed     Text format     Abstract available
   
   
8. DAVIDS BJ, Liu CM, Hanson EM, Le C, et al
   Identification of conserved candidate vaccine antigens in the surface proteome of Giardia lamblia.
   Infect Immun. 2019 Apr 8. pii: IAI.00219-19. doi: 10.1128/IAI.00219.
   PubMed     Text format     Abstract available
   
   
9. GIUNTINI S, Stoppato M, Sedic M, Ejemel M, et al
   Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection.
   Infect Immun. 2018;86.
   PubMed     Text format     Abstract available
   
   
10. JENNINGS-GEE J, Quataert S, Ganguly T, D'Agostino R Jr, et al
    The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
11. WANG Y, Wang S, Bouillaut L, Li C, et al
    Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

12. OSUNA CE, Whitney JB
    Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic Development.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
13. HU Y, Wang J, Zeng G, Chu K, et al
    Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial.
    J Infect Dis. 2019 Apr 8. pii: 5431722. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
14. SUTTER RW, Cochi SL
    Inactivated Poliovirus Vaccine Supply Shortage: Is There Light at the End of the Tunnel?
    J Infect Dis. 2019 Apr 8. pii: 5432103. doi: 10.1093.
    PubMed     Text format    
    
    
15. BRINKMAN ID, de Wit J, Smits GP, Ten Hulscher HI, et al
    Early measles vaccination during an outbreak in The Netherlands: reduced short and long-term antibody responses in children vaccinated before 12 months of age.
    J Infect Dis. 2019 Apr 11. pii: 5441452. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
16. MORENS DM, Fauci AS
    Pandemic Zika: A Formidable Challenge to Medicine and Public Health.
    J Infect Dis. 2017;216.
    PubMed     Text format    
    
    
17. BIERING-SORENSEN S, Jensen KJ, Monterio I, Ravn H, et al
    Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials.
    J Infect Dis. 2018;217:759-766.
    PubMed     Text format     Abstract available
    
    
18. PRIYAMVADA L, Suthar MS, Ahmed R, Wrammert J, et al
    Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

19. KUEHN B
    Measles Vaccine Exemptions.
    JAMA. 2019;321:1344.
    PubMed     Text format    
    
    

    
    Lancet

20. MOSSER JF, Gagne-Maynard W, Rao PC, Osgood-Zimmerman A, et al
    Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study.
    Lancet. 2019 Apr 5. pii: S0140-6736(19)30226.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Infect Dis

21. TEMPLE B, Toan NT, Dai VTT, Bright K, et al
    Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.
    Lancet Infect Dis. 2019 Apr 8. pii: S1473-3099(18)30734.
    PubMed     Text format     Abstract available
    
    
22. NELSON R
    Hepatitis A outbreak in the USA.
    Lancet Infect Dis. 2018;18:33-34.
    PubMed     Text format    
    
    
23. THE LANCET INFECTIOUS DISEASES
    How to be ready for the next influenza pandemic.
    Lancet Infect Dis. 2018;18:697.
    PubMed     Text format    
    
    
24. MADHI SA, Goldblatt D
    The duopoly of ten-valent and 13-valent pneumococcal conjugate vaccines: do they differ?
    Lancet Infect Dis. 2019 Apr 8. pii: S1473-3099(18)30785.
    PubMed     Text format    
    
    

    
    MMWR Morb Mortal Wkly Rep

25. BRENNAN J, Moore K, Sizemore L, Mathieson SA, et al
    Notes from the Field: Acute Hepatitis A Virus Infection Among Previously Vaccinated Persons with HIV Infection - Tennessee, 2018.
    MMWR Morb Mortal Wkly Rep. 2019;68:328-329.
    PubMed     Text format    
    
    

    
    Nat Med

26. HAMMERICH L, Marron TU, Upadhyay R, Svensson-Arvelund J, et al
    Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination.
    Nat Med. 2019 Apr 8. pii: 10.1038/s41591-019-0410.
    PubMed     Text format     Abstract available
    
    

    
    Pediatr Infect Dis J

27. OMER SB, Clark DR, Aqil AR, Tapia MD, et al
    Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants: Analysis of Randomized Controlled Trials Conducted in Nepal, Mali, and South Africa.
    Pediatr Infect Dis J. 2018 Feb 13. doi: 10.1097/INF.0000000000001914.
    PubMed     Text format     Abstract available
    
    

    
    Pediatrics

28. SHANG M, Blanton L, Brammer L, Olsen SJ, et al
    Influenza-Associated Pediatric Deaths in the United States, 2010-2016.
    Pediatrics. 2018 Feb 12. pii: peds.2017-2918. doi: 10.1542/peds.2017-2918.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

29. MESA KA, Yu B, Wrin T, Petropoulos CJ, et al
    Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.
    PLoS One. 2019;14:e0213409.
    PubMed     Text format     Abstract available
    
    
30. RAJAMOORTHY Y, Radam A, Taib NM, Rahim KA, et al
    Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey.
    PLoS One. 2019;14:e0215125.
    PubMed     Text format     Abstract available
    
    

    
    Science

31. LARSON HJ, Schulz WS
    Reverse global vaccine dissent.
    Science. 2019;364:105.
    PubMed     Text format    
    
    

    
    Vaccine

32. SANDO E, Suzuki M, Furumoto A, Asoh N, et al
    Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30447.
    PubMed     Text format     Abstract available
    
    
33. EL SAHLY HM, Atmar RL, Patel SM, Bellamy A, et al
    Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30420.
    PubMed     Text format     Abstract available
    
    
34. LIMA L, Molina MDGF, Pereira BS, Nadaf MLA, et al
    Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30419.
    PubMed     Text format     Abstract available
    
    
35. GAGNEUR A, Bergeron J, Gosselin V, Farrands A, et al
    A complementary approach to the vaccination promotion continuum: An immunization-specific motivational-interview training for nurses.
    Vaccine. 2019 Apr 3. pii: S0264-410X(19)30425.
    PubMed     Text format     Abstract available
    
    
36. HAVERI A, Ikonen N, Kantele A, Anttila VJ, et al
    Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
    Vaccine. 2019 Apr 3. pii: S0264-410X(19)30427.
    PubMed     Text format     Abstract available
    
    
37. BRUMMAIER T, Poe Yen Yen S, Keereecharoen D, McGready R, et al
    The natural course of a localized BCG vaccine abscess.
    Vaccine. 2019 Apr 2. pii: S0264-410X(19)30415.
    PubMed     Text format    
    
    
38. WENTWORTH D, Hampson K, Thumbi SM, Mwatondo A, et al
    A social justice perspective on access to human rabies vaccines.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30150.
    PubMed     Text format     Abstract available
    
    
39. REGAN AK, Fielding JE, Chilver MB, Carville KS, et al
    Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.
    Vaccine. 2019 Apr 2. pii: S0264-410X(19)30222.
    PubMed     Text format     Abstract available
    
    
40. KAWADE A, Babji S, Kamath V, Raut A, et al
    Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30416.
    PubMed     Text format     Abstract available
    
    
41. ECHEVARRIA D, Gutfraind A, Boodram B, Layden J, et al
    Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Vaccine. 2019 Apr 5. pii: S0264-410X(19)30319.
    PubMed     Text format     Abstract available
    
    
42. CHAMBERLAIN AT, Limaye RJ, O'Leary ST, Frew PM, et al
    Development and acceptability of a video-based vaccine promotion tutorial for obstetric care providers.
    Vaccine. 2019 Apr 5. pii: S0264-410X(19)30305.
    PubMed     Text format     Abstract available
    
    
43. KEERSMAEKERS N, Ogunjimi B, Van Damme P, Beutels P, et al
    An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix.
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30424.
    PubMed     Text format     Abstract available
    
    
44. CLARKE RM, Paterson P, Sirota M
    Determinants of satisfaction with information and additional information-seeking behaviour for the pertussis vaccination given during pregnancy.
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30446.
    PubMed     Text format     Abstract available
    
    
45. SCHARTAU S, Heering Holt D, Lutzen T, Rytter D, et al
    On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015.
    Vaccine. 2019 Apr 6. pii: S0264-410X(19)30391.
    PubMed     Text format     Abstract available
    
    
46. CHARANIA NA, Gaze N, Kung JY, Brooks S, et al
    Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature, 2006 to 2016.
    Vaccine. 2019 Apr 6. pii: S0264-410X(19)30437.
    PubMed     Text format     Abstract available
    
    
47. LECOUTURIER V, Bernard MC, Berry C, Carayol S, et al
    Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice.
    Vaccine. 2019 Apr 6. pii: S0264-410X(19)30451.
    PubMed     Text format     Abstract available
    
    
48. CROWCROFT NS, Schwartz KL, Chen C, Johnson C, et al
    Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015.
    Vaccine. 2019 Apr 6. pii: S0264-410X(19)30254.
    PubMed     Text format     Abstract available
    
    
49. INOUE M, Yonemura T, de Solom R, Yamaji M, et al
    A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults.
    Vaccine. 2019 Apr 5. pii: S0264-410X(19)30325.
    PubMed     Text format     Abstract available
    
    
50. ODUTOLA A, Ota MOC, Antonio M, Ogundare EO, et al
    Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30355.
    PubMed     Text format     Abstract available
    
    
51. TAUCHER C, Kollaritsch H, Dubischar KL
    Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO(R) in healthy adults: A five year follow-up study.
    Vaccine. 2019 Apr 5. pii: S0264-410X(19)30352.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: